We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CTKB

Price
3.65
Stock movement down
-0.02 (-0.55%)
Company name
Cytek Biosciences Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
470.16M
Ent value
413.65M
Price/Sales
2.34
Price/Book
1.22
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
17.38
PEG
-
EPS growth
-
1 year return
-38.86%
3 year return
-29.03%
5 year return
-
10 year return
-
Last updated: 2025-04-18

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

CTKB does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF14.29
Price to FCF16.38
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.34
Price to Book1.22
EV to Sales2.06

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count128.81M
EPS (TTM)-0.08
FCF per share (TTM)0.22

Income statement

Loading...
Income statement data
Revenue (TTM)201.21M
Gross profit (TTM)110.50M
Operating income (TTM)-23.65M
Net income (TTM)-10.16M
EPS (TTM)-0.08
EPS (1y forward)0.21

Margins

Loading...
Margins data
Gross margin (TTM)54.92%
Operating margin (TTM)-11.75%
Profit margin (TTM)-5.05%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash162.27M
Net receivables52.63M
Total current assets390.19M
Goodwill16.18M
Intangible assets20.49M
Property, plant and equipment0.00
Total assets491.23M
Accounts payable5.39M
Short/Current long term debt8.99M
Total current liabilities62.80M
Total liabilities105.76M
Shareholder's equity385.46M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)32.89M
Capital expenditures (TTM)4.19M
Free cash flow (TTM)28.70M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-2.64%
Return on Assets-2.07%
Return on Invested Capital-2.64%
Cash Return on Invested Capital7.45%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.65
Daily high3.68
Daily low3.47
Daily Volume425K
All-time high27.93
1y analyst estimate8.40
Beta1.32
EPS (TTM)-0.08
Dividend per share-
Ex-div date-
Next earnings date5 Jun 2025

Downside potential

Loading...
Downside potential data
CTKBS&P500
Current price drop from All-time high-86.93%-14.12%
Highest price drop-87.93%-56.47%
Date of highest drop8 Apr 20259 Mar 2009
Avg drop from high-62.65%-11.07%
Avg time to new high118 days12 days
Max time to new high902 days1805 days
COMPANY DETAILS
CTKB (Cytek Biosciences Inc) company logo
Marketcap
470.16M
Marketcap category
Small-cap
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Employees
645
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...